Brief: Santhera: 2022 Revenue From Contracts With Customers Of CHF 7.5 Mln
April 27 (Reuters) - Santhera Pharmaceuticals Holding Ag
SANN.S :
* SANTHERA ANNOUNCES PRELIMINARY UNAUDITED 2022 ANNUAL
RESULTS
AHEAD OF FULL REPORT PUBLICATION BY END OF MAY AND PROVIDES
CORPORATE UPDATE
* REVENUE FROM CONTRACTS WITH CUSTOMERS OF CHF 7.5 MILLION
* OPERATING RESULT OF CHF -52.0 MILLION (2021: CHF -56.9
MILLION)
AND NET RESULT OF CHF -70.1 MILLION (2021: CHF -55.5 MILLION)
Source text for Eikon: ID:nGNE458n4l
Further company coverage: SANN.S
(Reporting by Berlin Newsroom)
((berlin.newsroom@thomsonreuters.com;))
Recent news on Santhera Pharmaceuticals Holding AG
See all newsSwitzerland's Santhera Pharma H1 revenue soars on AGAMREE sales, milestones
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -6.562 Million
Brief: Santhera Says NXERA Plans To Submit South Korea Marketing Authorization Application 2026
Brief: Santhera Gets Positive CHMP Opinion To Expand Agamree (Vamorolone) Use
Brief: Santhera Pharmaceuticals H1 Operating Income CHF -35.444 Million